Cancer at Cedars-Sinai is now recruiting patients with advanced NSCLC in a clinical trial

Cancer at Cedars-Sinai posted on X/Twitter:

“If you have advanced non-small cell lung cancer, you may be eligible for a clinical trial that compares usual treatment options to a study treatment combining Keytruda (pembrolizumab) and Cyramza (ramucirumab).”